Predictive biomarkers in patients with locally advanced rectal cancer
The PIONEER project is to develop two innovative and reliable tests enabling physicians to predict response of patients to preoperative chemoradiotherapy (PCRT) in rectal cancer. The project’s goal is the identification and clinical validation of a composite algorithm based on microRNA (miRNA) and messenger RNA biomarkers. A consortium including AMC, Theradiag group and CBSBIO, has been established to fulfill this ambitious project from prospective sample collection to product commercialization.
2 178 340.00€
In vitro Testing, Trials
Diagnostic test products and equipment